Law360 Names Cravath a 2021 “Competition Practice Group of the Year”
February 16, 2022
On February 4, 2022, Cravath was featured by Law360 as a “Competition Practice Group of the Year,” receiving the distinction for the fourth time in five years. The Firm was recognized for its role representing clients on matters including winning the vacatur of a class certification order on appeal in a key victory for Qualcomm at the Ninth Circuit, and advising Mylan on merger clearance issues related to its $50 billion combination with Upjohn, a division of Pfizer, which won the FTC’s divided approval.
Cravath partner Christine A. Varney spoke about helping clients navigate a more aggressive FTC, while partner Yonatan Even addressed the massive scope of Cravath’s work for Qualcomm, which required careful coordination across cases.
Related Practices & Industries
People
- Photo
-
-
J.D., 1986, Georgetown University Law Center
-
M.P.A., 1982, Syracuse University
-
B.A., 1977, State University of New York, Albany
- New York
- District of Columbia
Education
Admitted In
- Photo
-
-
J.S.D., 2009, Columbia Law School
-
LL.M., 2004, Columbia Law SchoolJames Kent Scholar
-
LL.B., 1999, Tel Aviv Universitymagna cum laude
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
October 01, 2021
Qualcomm Wins Vacatur of Class Certification Order on Appeal
On September 29, 2021, the United States Court of Appeals for the Ninth Circuit ruled in favor of Cravath client Qualcomm Incorporated (“Qualcomm”), vacating a class certification order in Stromberg v. Qualcomm, a class action suit that is related to a prior antitrust suit brought against Qualcomm by the Federal Trade Commission (“FTC”), FTC v. Qualcomm. The Stromberg plaintiffs brought antitrust claims against Qualcomm, and the formerly certified class included an estimated 250 million members in the U.S.
Deals & Cases
August 13, 2020
Qualcomm Wins on Appeal Against FTC in Antitrust Suit
On August 11, 2020, the United States Court of Appeals for the Ninth Circuit ruled in favor of Cravath client Qualcomm Incorporated, a leading innovator of cellular technology, in its appeal from an adverse California federal court decision in an antitrust lawsuit filed by the Federal Trade Commission (“FTC”). In a complete defense victory for Qualcomm, the three‑judge panel for the Ninth Circuit unanimously reversed the district court’s judgment and vacated a permanent, worldwide injunction that prohibited several of Qualcomm’s core business practices.
Deals & Cases
July 29, 2019
Mylan’s $50 Billion Combination with Upjohn, a Division of Pfizer
On July 29, 2019, Mylan N.V. and Pfizer Inc. announced a definitive agreement to combine Mylan with Upjohn, Pfizer's off-patent branded and generic established medicines business, creating a new global pharmaceutical company. Under the terms of the agreement, which is structured as an all-stock, Reverse Morris Trust transaction, each Mylan share would be converted into one share of the new company. Pfizer shareholders would own 57% of the combined new company, and Mylan shareholders would own 43%. Cravath is representing Mylan in connection with the transaction.
